Clinical trial

Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

NCT02971293

Study summary

ClinicalTrials.gov

Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention AZD8871 100 µg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention AZD8871 600 µg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-15

PhasePHASE2

Conditions

Chronic Obstructive Pulmonary Disease COPDunresolved

Interventions

AZD8871 100 µgDRUG

AZD8871 600 µgDRUG

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Parexelcollaborator

Mapped research locations

BerlinGermany1 ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02971293 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.